Full-Time

Senior Manager

Facilities & Lab Operations

Confirmed live in the last 24 hours

Editas Medicine

Editas Medicine

201-500 employees

Develops gene editing treatments using CRISPR

Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelor’s or Master’s degree in biology or a related field, and 8+ years of relevant experience working in facility and lab operations in a biotech company
  • DOT, IATA/DG Certified
  • Experience with procurement of lab common supplies, lab inventory management system, and working with external vendors
  • Expertise in contract/quotation negotiations, shipping/receiving is required
  • Knowledge of lab safety and OSHA regulations and safety training is required.
  • Experience with permitting, training, and reporting requirements as set forth by local, state, and federal regulations is preferred
  • Strong organizational, communication and interpersonal skills are required
  • Experience of optimizing and centralizing processes across groups is preferred
  • Experience with 5'S' or Lean principles is preferred
  • Experience with cell culture, protein expression and purification are a plus
Responsibilities
  • Oversee any construction, building repair, and maintenance programs.
  • Manage and oversee shipping for domestic and international shipments of materials, including the preparation of material for shipment and receiving from external vendors.
  • Anticipate, troubleshoot, and resolve problems associated with work within the facility, including occasional off-hours responses to emergencies.
  • Establish procedures; create and manage related documentation, and organizational processes such as annual laboratory cleanouts, de-frosting of freezers, HVAC maintenance, cold room maintenance, freezer/refrigerator inventory, and consumables inventory.
  • Manage cryogenics and compressed gases, including but not limited to placing requests with external vendor, monitoring, and swapping out cylinders and dewars, as needed.
  • Collaborate regularly with scientists to identify and address any workflow bottlenecks, inefficiencies, opportunities for process improvement, and logistical or administrative issues in the lab.
  • Support lab safety and regulatory compliance, including tracking biologics, chemicals, and hazardous materials, and enforcing PPE Policy and lab safety rules.
  • Handle and track biological waste and hazardous waste.
  • Manage laboratory space to maximize effective square footage, factoring equipment utilization, workflow, and assigned bench allocations.
  • Assist and support CapEx process, from conducting equipment specification assessments and space planning.
  • Collaborate with internal partners including HR, Legal, Procurement, IT, etc.
  • Contribute to the management of the Lab and Facilities Operations budget.
  • Oversee the general lab and facility organization and cleanliness.
  • Assist and support the permitting process.
  • In partnership with EHS, perform routine lab safety inspections and walkthroughs, and participate in monthly safety committee meetings.
  • Devise and implement Facility related SOP’s and Policies, such as Shipping SOP, Parking Policy, etc.

Editas Medicine focuses on gene editing using CRISPR technology, which allows for precise modifications to DNA in cells. This technique has the potential to correct genetic defects that lead to various diseases. The company is engaged in the entire process of drug development, from discovering new treatments to manufacturing and bringing them to market. Editas Medicine aims to create long-lasting therapies that can greatly enhance the quality of life for patients suffering from serious illnesses. Unlike many competitors, Editas has a diverse pipeline of experimental medicines and actively shares clinical data to keep stakeholders informed. The ultimate goal is to provide effective treatments for patients worldwide, while also generating revenue through partnerships and commercialization of their genomic medicines.

Company Stage

IPO

Total Funding

$884.6M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

10%

1 year growth

22%

2 year growth

16%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful clinical trials, like the EDIT-101 for Leber Congenital Amaurosis, demonstrate the potential for groundbreaking treatments.
  • The extension of collaborations with major pharmaceutical companies like Bristol Myers Squibb indicates strong industry validation and potential for future growth.
  • Recent investments, such as the $23.36 million from Marshall Wace LLP, reflect confidence in the company's innovative approach and financial stability.

What critics are saying

  • The highly competitive field of gene editing requires continuous innovation to maintain a leading position.
  • Regulatory hurdles and ethical concerns surrounding gene editing could delay or impede the commercialization of treatments.

What makes Editas Medicine unique

  • Editas Medicine leverages CRISPR technology to develop transformative treatments for serious diseases, setting it apart from traditional biotech firms.
  • The company's comprehensive approach, from discovery to commercialization, ensures a streamlined process for bringing genomic medicines to market.
  • Editas Medicine's strategic partnerships, such as with Bristol Myers Squibb, enhance its capabilities in developing gene-edited therapies.

Help us improve and share your feedback! Did you find this helpful?